FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall

被引：0

|

作者：

Wilson, Mark

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 380卷

关键词：

D O I：

10.1136/bmj.p85

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[31] Report criticizes lack of FDA oversight
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (08): : 920 - 922
[32] GAO: FDA Oversight of Produce Is Poor
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18): : 2106 - 2107
[33] Expansion of FDA oversight power sought
不详
ISSUES IN SCIENCE AND TECHNOLOGY, 2008, 24 (02) : 17 - 18
[34] US device industry and FDA "colluded" on legislation to weaken regulatory oversight (vol 351, h6820, 2015)
Zuckerman, Diana
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[35] FDA BOOSTS OVERSIGHT OF IMPORTED FOOD
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (31) : 24 - 24
[36] A Brief History of FDA Compounding Oversight
Shulman, Stanford T.
PEDIATRIC ANNALS, 2013, 42 (01):
[37] US FDA recommendations on cardio risk in diabetes trials
Reactions Weekly, 2009, 1234 (1) : 2 - 2
[38] US FDA suspends SCID gene therapy trials
Reactions Weekly, 2005, 1044-1045 (1) : 3 - 3
[39] FDA Rules on Clinical Trials Safety Information
Lang, Les
GASTROENTEROLOGY, 2010, 139 (06) : 1805 - 1806
[40] FDA GUIDELINE ON WOMEN IN CLINICAL-TRIALS
NIGHTINGALE, SL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (11): : 1290 - 1290

← 1 2 3 4 5 →